Drug Shortage Report for SUBLINOX
| Report ID | 238527 |
| Drug Identification Number | 02391678 |
| Brand name | SUBLINOX |
| Common or Proper name | SUBLINOX |
| Company Name | BAUSCH HEALTH, CANADA INC. |
| Market Status | MARKETED |
| Active Ingredient(s) | ZOLPIDEM TARTRATE |
| Strength(s) | 5MG |
| Dosage form(s) | TABLET (ORALLY DISINTEGRATING) |
| Route of administration | SUBLINGUAL SUBLINGUAL |
|
Packaging sizes (GTIN)
Click here to see a list of all reports for this drug. |
(See additional packaging sizes) |
| Additional packaging sizes | n/a |
| ATC code | N05CF |
| ATC description | HYPNOTICS AND SEDATIVES |
| Reason for shortage | Delay in shipping of the drug. |
| Anticipated start date | 2024-10-02 |
| Actual start date | |
| Estimated end date | 2024-12-16 |
| Actual end date | 2024-10-01 |
| Shortage status | Avoided shortage |
| Updated date | 2024-10-03 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 2150 BOUL. ST-ELZEAR OUEST LAVAL, QUEBEC CANADA H7L 4A8 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v5 | 2024-10-03 | French | Compare |
| v4 | 2024-10-03 | English | Compare |
| v3 | 2024-10-03 | English | Compare |
| v2 | 2024-09-25 | French | Compare |
| v1 | 2024-09-25 | English | Compare |
Showing 1 to 5 of 5